Cerebroprotective activity of 3-benzylxanthine derivative – compound Ale-15, in conditions of bilateral common carotid arteries ligation (ischemic stroke)

Sergey V. Levich, Katherine V. Aleksandrova, Igor F. Belenichev, Alexander S. Shkoda


Background: Acute ischemic stroke is a leading cause of mortality, morbidity, long-term disability in industrialized countries. One of main parts of it pathogenesis is production of reactive oxygen species. The accumulation of them in neurons results in lipid peroxidation, protein oxidation, DNA damage, and finally cell death. Thereby the search of novel drugs, that have antioxidant action and can be used to complex treatment of cerebral strokes is reasonable. It is known, that xanthine derivatives exhibit a broad spectrum of biological activity, including antioxidant. So that, the goal of this research was to study in vivo neuroprotective action of water-soluble derivative of 3-benzylxanthine – morpholin-4-ium 3-benzylxanthinyl-8-methylthioacetate (Ale-15 compound) in comparison with neuroprotector-antioxidant – Mexidol.

Methods: Experimental part was done on white Wistar rats of both sexes of 220-260 g weight. For assessment of neuroprotective action of compound we used a model of global incomplete cerebral ischemia, that was reproduced by bilateral common carotid arteries ligation.

Results: It was studied an acute toxicity of Ale-15 compound, it influence on survival of laboratory animals, on progression of neuralgic deficit, on the content of adenylic nucleotides, on criteria of energy metabolism, on the activity of antioxidant enzymes and on oxidative modification of protein. Results of study showed, that injection of Ale-15 compound to animals with ischemic stroke intragastrically during 4 days positively reduced death rate and quantity of animals with serious neurologic symptoms. The main parts of Ale-15 cerebroprotective mechanism are antioxidant and anti-ischemic actions.

Conclusions: The performed study revealed significant cerebroprotective features of Ale-15 compound in conditions of experimental cerebrovascular accident.


Xanthine, Antioxidant activity, Cerebroprotective action, Ischemic stroke

Full Text:



WHO. Disease and Injury Country Estimates. Geneva. 2009.

Gusev EL, Skvortsova VI. Brain ischemia. 1st ed. Moscow, M: Meditsina Publishers: 2001:326.

Alexandrova ML and Bochev PG. Oxidative stress in stroke. In: Ali Qureshi G, Hassan Parves S, eds. Oxidative stress and neurodegenerative disorders. 1st ed. Amsterdam, London: Elsevier; 2007:313-368.

McColl BW, Allan SM and Rothwell NJ. Systemic infection inflammation and acute ishemic stroke. Neurosci 2009;158:1049-1061.

Coyle JT and Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993;262:689-695.

Satoh T, Enokido Y, Kubo K, Yamada M and Hatanaka H. Oxygen toxicity induces apoptosis in neuronal cells. Cell Mol Neurobiol 1999;18:649-666.

Satoh T and Lipton SA. Redox regulation of neuronal survival by electrophilic compounds. Trends Neurosci 2007;30:37-45.

Satoh T, Okamoto S, Cui J, Watanabe Y, Furuta K, Suzuki M et al. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic phase II inducers. Proc Natl Acad Sci USA 2006;103:768-773.

Satoh T and Izumi M. Neuroprotective effects of phenylenediamine derivatives independent of an antioxidant pathway in neuronal HT22 cells. Neurosci Let 2007;418:102–105.

Chiueh CC. Neurobiology of NO and OH: basic research and clinical relevance. Ann N Y Acad Sci 1994;738:279-281.

Scott B and Auroma O. Oxidative stress, oxidants and antioxidants. Exp Physiol 1999;8:291-295.

Ullegaddi R, Powers HJ and Gariballa SE. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischemic stroke. Eur J Clin Nutr 2005;59:1367-1373.

Bhat VB and Madyastha KM. Antioxidant and radical scavenging properties of

-oxoderivatives of xanthine drugs pentoxifylline and lisofylline. Biochem and Biophys Res Commun 2001;288:1212–1217.

Barth A, Kaiser N, Leffler U, Sourgens H and Klinger W. Influence of the xanthine derivative denbufylline and the antiinflammatory agent nabumetone on microsomal free radical production and lipid peroxidation in rat liver. Exp Toxic Pathol 1994;46:483-489.

Aleksandrova KV, Belenichev IF, Shkoda AS, Buhtiyarova NV, Levich SV. Pat. UA 54957 U. In. Cl. С 07 D 473/00. Water-soluble salts of 3-benzylxanthinyl-8-methylthioacetic acid, exhibiting antioxidant action. № u201007741; Pub. date. 25.11.2010. Bul. № 22.

Gnezdilova A, Ganshina T and Mirzoyan R. Cerebrovascular effects of mexidol in conditions of separate and combined vascular pathology of brain and heart. Eur Neuropsychopharmacology 2011; Suppl 2:S124.

Tilekeyeva UM and Sitina LI. Stress-protective effect of mexidol on different levels of natural altitudes. Eur Neuropsychopharmacology 2005; Suppl 2:S209.

Loit AО and Savchenikov MF. Prophylactic toxicology: a guide for toxicologists experimenters. 1st ed. Irkutsk, I: Irkutskiy University Publishers; 1996: 76-77.

Sidorov КК. Toxicology of new industrial chemicals. 1st ed. Moscow, M: Meditsina Publishers; 1973: 47.

Carmichael ST. Rodent models of focal stroke: size, mechanism and purpose. NeuroRX 2005;2(3):396-409.

Prohorova MI. Modern methods of biochemical investigations (lipid and energy metabolism. 1st ed. Leningrad, L: Leningradskiy University Publishers; 1982: 272.

Chevari S, Chaba I and Sekeĭ I. Role of superoxide dismutase in cellular oxidative processes and method of its determination in biological materials. Lab Delo 1985;11:678-81.

Korolyuk МА. The method of determining the activity of catalase. Lab Delo 1988;1:16-19.

Belenichev IF and Maksimenko SF. Changes in the activity of glutathione peroxidase in patients with occlusive vascular lesions of the optic nerve. J Ophtalmol 1996;3:150-153.

Halliwell B., Gutteridze JM. Free radicals in biology and medicine. 1st ed. Oxford, O: Clarendon Press; 1985: 346.

Halliwell B. Molecular biology of free radicals in human diseases. 1st ed. St. Lucia, London, L: OICA; 1999: 410.

Chance B. Optical method. Annu Rev Biophys Biophys Chern 1991;20:1-28.

Hohorst HJ. Enzymatic method of the lactate concentration in blood. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. 1st ed. Weinheim, Bazel, B: Verl Chemie; 1970: 1425.

McGrow CP. Experimental cerebral infarction effects of pentobarbital in mongolian gerbils. Arch Neurol 1977;34(6):334-336.

Zaycev VM, Liflyandskiy VG and Marinkin VI. Applied Medical Statistics: Textbook. 1st ed. Saint Petersburg, SP: Foliant Publishers; 2006: 432.

Ozkul A, Akyol A, Yenisey C, Arpaci E, Kiylioglu N and Tataroglu C. Oxidative stress in acute ischemic stroke. J Clin Neurosci 2007;14:1062-1066.

Liu TH, Beckman JS, Freeman BA, Hogan EL and Hsu CY. Polyhethylene glycol-conjugated superoxidedismutase and catalase reduce ischemic brain injury. Am J Physiol 1989;256:589-593.

Manzanero S, Santro T and Arumugam TV. Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury. Neurochem Int 2013;62(5):712-718.